Showing results (231-240 of 304) with videos related to

Sort By:
Pageof 31
Oncogenesis|July 17, 2013
RAF kinase inhibitor-independent constitutive activation of Yes-associated protein 1 promotes tumor progression in thyroid cancerS E Lee, J U Lee, M H Lee, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 31, 2014
Lysophosphatidylcholine as a prognostic marker in community-acquired pneumonia requiring hospitalization: a pilot studyW H Cho, H J Yeo, S H Yoon, et al.
Clinical Genetics|September 11, 2002
Three novel mutations of the PKD1 gene in Korean patients with autosomal dominant polycystic kidney diseaseH-S Eo, J G Lee, C Ahn, et al.
Bone Marrow Transplantation|March 26, 2014
PBSC vs BM grafts with myeloablative conditioning for unrelated donor transplantation in adults with high-risk ALLS-H Shin, J-H Yoon, S-A Yahng, et al.
Bone Marrow Transplantation|August 12, 2014
Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantationJ-H Yoon, H-J Kim, J-W Kim, et al.
Bone Marrow Transplantation|June 28, 2016
Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioningS H Shin, Y W Jeon, J H Yoon, et al.
Cell Death and Differentiation|June 4, 2011
Ret finger protein inhibits muscle differentiation by modulating serum response factor and enhancer of polycomb1H J Kee, J-R Kim, H Joung, et al.
Bone Marrow Transplantation|November 7, 2012
Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failureS-H Shin, S-A Yahng, J-H Yoon, et al.
Leukemia|June 19, 2012
Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemiaS Lee, D-W Kim, B-S Cho, et al.
Bone Marrow Transplantation|July 30, 2013
Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?J-H Yoon, W-S Min, H-Je Kim, et al.
Pageof 31